Two Sigma Advisers’s Lipocine LPCN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,822
| Closed | -$106K | – | 2413 |
|
|
2024
Q2 | $106K | Sell |
12,822
-12,900
| -50% | -$106K | ﹤0.01% | 2316 |
|
|
2024
Q1 | $134K | Sell |
25,722
-500
| -2% | -$2.6K | ﹤0.01% | 2280 |
|
|
2023
Q4 | $73.2K | Sell |
26,222
-30,700
| -54% | -$85.7K | ﹤0.01% | 2361 |
|
|
2023
Q3 | $170K | Buy |
+56,922
| New | +$170K | ﹤0.01% | 2128 |
|
|
2023
Q2 | – | Sell |
-7,765
| Closed | -$42K | – | 2544 |
|
|
2023
Q1 | $42K | Sell |
7,765
-1,794
| -19% | -$9.7K | ﹤0.01% | 2466 |
|
|
2022
Q4 | $64.6K | Sell |
9,559
-2,770
| -22% | -$18.7K | ﹤0.01% | 2341 |
|
|
2022
Q3 | $94K | Sell |
12,329
-5,883
| -32% | -$44.9K | ﹤0.01% | 2315 |
|
|
2022
Q2 | $248K | Buy |
18,212
+9,836
| +117% | +$134K | ﹤0.01% | 2190 |
|
|
2022
Q1 | $195K | Buy |
8,376
+5,258
| +169% | +$122K | ﹤0.01% | 2389 |
|
|
2021
Q4 | $53K | Buy |
+3,118
| New | +$53K | ﹤0.01% | 2469 |
|
|
2021
Q2 | – | Sell |
-1,524
| Closed | -$39K | – | 2581 |
|
|
2021
Q1 | $39K | Buy |
+1,524
| New | +$39K | ﹤0.01% | 2508 |
|
|
2020
Q4 | – | Sell |
-888
| Closed | -$21K | – | 2498 |
|
|
2020
Q3 | $21K | Sell |
888
-200
| -18% | -$4.73K | ﹤0.01% | 2359 |
|
|
2020
Q2 | $23K | Buy |
+1,088
| New | +$23K | ﹤0.01% | 2457 |
|